REDEMPLO now available to FCS patients in England and Wales via NHS

Arrowhead Pharmaceuticals announced that adults in England and Wales living with Familial Chylomicronaemia Syndrome (FCS) now have access to REDEMPLO (plozasiran) through the National Health Service (NHS).

Detected & updated continuously · Source: Nebula